Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-04-05
1992-12-15
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514921, A61K 3702
Patent
active
051717395
ABSTRACT:
The present invention provides a method for preventing endotoxin-associated shock in a subject which comprises administering to the subject an amount of a BPI protein effective to bind to endotoxin so as to prevent endotoxin associated shock in the subject. This invention further provides a method for treating a subject suffering from endotoxin-associated shock which comprises administering to the subject an amount of a BPI protein effective to bind endotoxin so as to treat the subject suffering from endotoxin-associated shock.
REFERENCES:
patent: 84335 (1987-08-01), Elsbach
M. N. Marra, et al., (1990) J. Immunol., 144:662-666, (Exhibit A).
P. Elsbach, et al., (1988) Bacteria-Host Cell Interaction, pp. 47.varies.60 (Exhibit B).
P. Gray et al., (1988) Clinical Research, 36(3):620A (Exhibit C).
P. Gray et al., (1989) The Journal of Biological Chemistry 264(16):9505 (Exhibit D).
J. Weiss et al., (1982) The American Society of Clinical Investigation, Inc. 69:959 (Exhibit F).
J. Weiss et al., (1985) The American Society of Clinical Investigation, Inc., 76:206 (Exhibit G).
S. Leong, et al., J. Cell Biochem. Suppl. 13:66 (1989) (Exhibit J).
J. Weiss, et al., Infection and Immunity, 38:1149-1153 (1982) (Exhibit K).
K. Muello, et al., Clinical Research, 31:371A (Exhibit L).
J. Weiss et al., J. Clin. Invest., 71:540-549 (1983) (Ex. M).
W. M. Shafer, et al., Infection and Immunity, 45:29-35 (1984) (Exhibit N).
C. J. Hovde, et al., Infection and Immunity, 54:142-148 (1986) (Exhibit O).
J. Weiss, et al., Infection and Immunity, 51:594-599 (1986) (Exhibit P).
J. K. Spitznagel, et al., J. Immunol. 139:1291-1296 (1987) (Exhibit Q).
M. M. Shafer, et al., Infection and Immunity, 55:1536-1539 (1987) (Exhibit R).
G. I. Veld, et al., Infection and Immunity, 56:1203-1208 (1988) (Exhibit S).
M. M. Farley, et al., Infection and Immunity, 56:1589-1592 (1988) (Exhibit T).
B. A. Mannion et al., J. Immunol. 142:2807-2812 (1989) (Ex U).
J. Weiss et al., (1985) ASCI Metabolism, 33(2):567(A) (Ex. V).
B. A. Mannion et al., J. Cin. Invest. 85:853-860 (1990) (Exhibit W).
A. H. Pereira, et al., Blood 76:825-834 (1990) (Exhibit X).
R. R. Schumann, et al., Science 249:1429-1431 (1990) (Exhibit Y); and.
Marra Marian N.
Scott Randal W.
Cashion Jr. Merrell C.
Incyte Pharmaceuticals Inc.
Koh Choon P.
White John P.
LandOfFree
Treatment of endotoxin-associated shock and preventation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of endotoxin-associated shock and preventation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of endotoxin-associated shock and preventation thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2092937